- Report
- April 2026
- 198 Pages
Global
From €7102EUR$7,990USD£6,164GBP
- Clinical Trials
- April 2026
- 450 Pages
Global
From €4445EUR$5,000USD£3,857GBP
- Report
- April 2026
- 328 Pages
Global
From €7102EUR$7,990USD£6,164GBP
- Report
- April 2026
- 592 Pages
Global
From €7102EUR$7,990USD£6,164GBP
- Report
- April 2026
- 335 Pages
Global
From €7102EUR$7,990USD£6,164GBP
- Report
- April 2026
- 450 Pages
Global
From €4445EUR$5,000USD£3,857GBP
- Drug Pipelines
- April 2026
- 280 Pages
Global
From €2667EUR$3,000USD£2,314GBP
- Report
- April 2026
- 981 Pages
Global
From €7102EUR$7,990USD£6,164GBP
- Report
- April 2026
- 280 Pages
Global
From €4445EUR$5,000USD£3,857GBP
- Report
- April 2026
Global
From €7102EUR$7,990USD£6,164GBP
- Clinical Trials
- April 2026
- 280 Pages
Global
From €2667EUR$3,000USD£2,314GBP
- Drug Pipelines
- April 2026
- 180 Pages
Global
From €2222EUR$2,500USD£1,929GBP
- Report
- April 2026
- 30 Pages
Global
From €2445EUR$2,750USD£2,121GBP
- Report
- April 2026
- 30 Pages
Global
From €2445EUR$2,750USD£2,121GBP
- Report
- April 2026
- 433 Pages
Global
From €7102EUR$7,990USD£6,164GBP
- Clinical Trials
- April 2026
- 180 Pages
Global
From €1778EUR$2,000USD£1,543GBP
- Report
- March 2026
- 30 Pages
Global
From €2445EUR$2,750USD£2,121GBP
- Drug Pipelines
- March 2026
- 150 Pages
Global
From €3333EUR$3,750USD£2,893GBP
- Report
- February 2026
- 200 Pages
Global
From €7102EUR$7,990USD£6,164GBP
- Report
- February 2026
- 200 Pages
Global
From €7102EUR$7,990USD£6,164GBP

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more